Obesity Clinical Trial
Official title:
Pilot Study of Laparoscopic Gastric Plication in Adolescents With Severe Obesity
NCT number | NCT01980758 |
Other study ID # | HM14809 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | May 2013 |
Est. completion date | March 8, 2018 |
Verified date | July 2018 |
Source | Virginia Commonwealth University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The proposed study aims to investigate the effects of laparoscopic gastric plication (LGP) on
excess body weight, body mass index, and weight-related medical and psychological
co-morbidities in obese adolescents. Additionally, we will evaluate the safety and efficacy
of this procedure (implemented within a multidisciplinary comprehensive lifestyle
modification program) on changes in the patients' medical status, psychosocial and
psychological functioning, physical fitness, and health-related quality of life.
Study hypothesis:
1. Laparoscopic gastric plication performed on carefully selected obese adolescents within
a multidisciplinary treatment program providing pre and post-surgical behavioral and
psychological support and education will result in: a) initial and sustained reductions
in excess body weight and body mass index, b) improvements in psychological functioning,
physical fitness, and health-related quality of life, and c) reduction in weight-related
comorbidities.
2. LGP will be a safe procedure, with complication rates that are comparable to or lower
than what has been found in other published reports of surgical weight loss procedures
used in obese adolescents.
Status | Completed |
Enrollment | 4 |
Est. completion date | March 8, 2018 |
Est. primary completion date | March 8, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 14 Years to 19 Years |
Eligibility |
Inclusion Criteria: - Age 14 - 19. - At physical maturity. - BMI of greater than or equal to 35 kg/m2 with major comorbidities, or BMI of greater than 40 kg/m2 with other weight related comorbidities. - Must have undergone comprehensive pre-surgical assessments by a multi-disciplinary team. - Must have at least 6 months of medically observed and attempted non-surgical weight loss. - Must have demonstrated suboptimal weight loss following participation in a lifestyle intervention. - Must have parents involved in all phases of recruitment and intervention. Exclusion Criteria: - Underlying genetic or endocrine disorder, which would preclude weight loss through behavioral and surgical techniques. - Less than six months of participation in a medically-supervised weight management efforts. - Active untreated, unstable psychopathology (to include active psychosis, severe depression, or significant eating pathology), as determined by psychological evaluation. - Active suicidal ideation, as determined by psychological evaluation. - Inadequate social support, as determined by psychological evaluation. - Inability to provide informed consent/assent, as evidenced by clinical interview and cognitive assessments. - Severe mental retardation, as evidenced by clinical interview and cognitive assessments. - Demonstrated pattern of poor adherence to medical regimen and lifestyle modification. - Active substance abuse, including tobacco use, as demonstrated by clinical interview and psychological evaluation. Inadequate knowledge of risks and patient responsibilities, as determined by clinical interview and knowledge quiz. - Reported pregnancy within the past year, current pregnancy, or planning to become pregnant in the next three years. - History or clinical symptoms of severe gastrointestinal reflux disease (GERD) - Person is not deemed for medical reasons to be a surgical candidate. |
Country | Name | City | State |
---|---|---|---|
United States | Children's Hospital of Richmond at VCU | Richmond | Virginia |
Lead Sponsor | Collaborator |
---|---|
Virginia Commonwealth University | Children's Hospital of Richmond |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Reduction of Excess Body Weight | 6 months post-surgery | ||
Secondary | Reduction in comorbidities to obesity | 6 months | ||
Secondary | Changes in lifestyle choices | 1 year | ||
Secondary | Improvement in quality of life | 3 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |